• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.62% Nasdaq Up 0.20%

    PTC Therapeutics, Inc. (PTCT)

    -NasdaqGS
    50.38 Down 3.50(6.50%) 2:17PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:53.88
    Open:53.56
    Bid:50.46 x 300
    Ask:50.58 x 200
    1y Target Est:100.67
    Beta:-0.46
    Next Earnings Date:30-Jul-15PTCT Earnings announcement
    Day's Range:49.89 - 53.56
    52wk Range:26.02 - 78.72
    Volume:339,784
    Avg Vol (3m):687,965
    Market Cap:1.71B
    P/E (ttm):N/A
    EPS (ttm):-3.49
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PTCT

    Comparison

    Symbol% ChgMkt Cap
    PTCTDown 6.50%1.71B
    SRPTDown 1.72%1.31B
    VRTXDown 1.95%30.66B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):76.74
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.74
    Quarterly EPS Est (Jun-15) :-1.20
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):1.29

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback